Companies - Galapagos

Price

 
Price
€ 91,42
Change
€ 0,32
Change %
0,35%
Open
€ 91,10
High
€ 92,58
Low
€ 89,40
Volume
395.987

Profile

 
Profile
Galapagos is a service company for the pharmaceutical companies. It is specialized in the discovery of proteins that cause disease. The company is also active in the development of new molecules. While it focuses on arthritis, osteoporosis and osteoarthritis.
Industry
Biotechnology
Description
Companies in the biotechnology industry are performing research and development activities for the purpose of discovering new drugs and diagnostics. The turnover of these companies comes from sales of these products or the sale of licenses of drugs and diagnostic to other companies.

Key figures (2017)

 
The ratios below are calculated using the last known share price and the last known company financials.

Ratios per share

Price to Earnings
-
Price to Earnings (3 years)
-
Price to Earnings (5 years)
-
Price to earnings growth
-
Price/cashflow
-
Price/net cashflow
-
Price/book value
-
Price to sales
-

Ratios for dividend

Dividend yield
-
Pay out
-

Valuation ratios

Market value/PE
-
Market value/turnover
-
Enterprise value/turnover
1,101

Return ratios

Return on private equity
-
Return on total equity
-9,00%
Profit margin
-74,20%

Risk ratios

Solvability
-
Solvability
-
Current ratio
-
Debt to Equity
-

Value invest ratios

Grahams Number
-
Grahams Value
-
Grahams Product
-
Grahams Product (3 years)
-

2017

 

Profit and loss

Net profit (x 1 mln)
€ -115,70
Turnover (x 1 mln)
€ 155,92
Cashflow(x 1 mln)
€ -111,42
Net cashflow(x 1 mln)
€ 205,78

Balance

Private equity (x 1 mln)
-
Foreign equity (x 1 mln)
-
Current assets (x 1 mln)
-
Current liabilities (x 1 mln)
€ 171,70
Working capital (x 1 mln)
€ -171,70
Balance total (x 1 mln)
€ 1.286,27

Share

Outstanding shares (x 1 mln)
-
Price year-end
€ 78,98
Dividend per share
-
Earnings per share
-
Cashflow per share
-
Net cashflow per share
-
Book value per share
-
Stockmarket value (x 1 mln)
-

History

 
Year
2017
2016
2015
2014
2013
Net profit (x 1 mln)
€ -115,70
€ 54,01
€ -118,40
€ 33,21
€ -8,08
Turnover (x 1 mln)
€ 155,92
€ 151,61
€ 60,60
€ 90,02
€ 159,55
Price year-end
€ 78,98
€ 60,94
€ 56,76
€ 15,49
€ 4,85
Year high
€ 89,75
€ 66,19
€ 60,55
€ 17,05
€ 4,85
Year low
€ 59,13
€ 32,50
€ 14,81
€ 4,85
€ 4,85
Outstanding shares (x 1 mln)
-
45,696
39,076
30,108
29,794
Price to Earnings
-
51,559
-18,733
14,043
-17,884
Earnings per share
-
€ 1,18
€ -3,03
€ 1,10
€ -0,27
Dividends
-
-
-
-
-
Dividend yield
-
-
-
-
-
Pay out
-
-
-
-
-
Private equity (x 1 mln)
-
€ 758,70
€ 365,00
€ 206,14
€ 167,14
PE per share
-
€ 16,60
€ 9,34
€ 6,85
€ 5,61
Balance total (x 1 mln)
€ 1.286,27
€ 1.083,34
€ 442,51
€ 270,47
€ 287,37
Stockmarket value (x 1 mln)
-
€ 2.784,71
€ 2.217,95
€ 466,37
€ 144,50

Company analysis

 

Analysis of profit indicators

Average profit per share (6 years)
€ -0,41
Standard deviation average profit
€ 1,45 (-352,09%)
Average annual growth rate
21,82%
Compound annual growth percentage
12,25%
© 2009 Skuzet. All Rights Reserved.